Healthcare ServicesCompany
Emergent BioSolutions M&A Summary
Emergent BioSolutions has acquired 11 companies. A total of 2 acquisitions came from private equity firms. It has also divested 1 asset.
Emergent BioSolutions’ largest acquisition to date was in 2018, when it acquired Adapt Pharma Operations for $735M. Emergent BioSolutions has acquired in 4 different US states, and 5 countries. The Company’s most targeted sectors include life science (64%) and medical products (19%).
Emergent BioSolutions Business Overview
Where is Emergent BioSolutions headquartered?
Emergent BioSolutions is headquartered in Gaithersburg, Maryland.
What is Emergent BioSolutions’ revenue?
Emergent BioSolutions disclosed revenue of 1,023M USD for 2023 and 1,076M USD for 2022.
How many employees does Emergent BioSolutions have?
Emergent BioSolutions has 1,600 employees.
What sector is Emergent BioSolutions in?
Emergent BioSolutions is a healthcare services company.
When was Emergent BioSolutions founded?
Emergent BioSolutions was founded in 1998.
M&A Summary
-
M&A Total Activity12
- M&A Buy Activity11
- M&A Sell Activity1
- Total Sectors Invested 3
- Total Countries Invested 5
- M&A Buy/Sell Connections 9
- M&A Advisors 7